Form 4: Pulmonx Director Glendon E. French III Sells 20,000 Shares
SEC Form 4 Filing
Director Glendon E. French III of Pulmonx Corp sold 20,000 shares of common stock on September 12, 2024, at a weighted average price of $8.09.
Summary
- On September 12, 2024, Glendon E. French III, a director of Pulmonx Corp, sold 20,000 shares of common stock.
- The sale was executed at a weighted average price of $8.09 per share.
- The transactions occurred within a price range of $7.67 to $8.43.
- Following the reported transaction, French directly owns 1,111,974 shares of Pulmonx Corp.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on June 10, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sentiment is neutral as it simply reports the sale of shares by a director.
Industry Context
Insider sales are common and can be for various reasons, not necessarily indicative of the company's performance. Monitoring insider transactions can provide insights, but should be considered with other factors.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder confidence, but is unlikely to be significant given the relatively small volume and the existence of a pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| June 10, 2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| September 12, 2024 | Date of the stock sale transaction |
| September 18, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.